Buying Bayer Diagnostics, Siemens Approaches Guided Therapy with Imaging, Immuno Dx | GenomeWeb

Medical imaging giant Siemens is joining rival GE Healthcare in the molecular diagnostics field by purchasing Bayer HealthCare's Diagnostics division.

Under the terms of the acquisition, announced last week, Siemens will buy the unit for $5.34 billion, and the transaction is expected to be complete in the first half of 2007. Bayer will retain its diabetes diagnostics unit under the Diabetes Care Division moniker.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.